CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $47.67 ($238,352)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at $35.10 ($1,404,024)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at $27.76 ($138,800)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at an average $30.07 ($1,202,638)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $29.58 ($295,839)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 1,230 shares at $26.18 ($32,196)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 45,000 shares at $26.17 ($1,177,862)
- 144 Insider Sale of Securities
Page 4 of 40 · 798 filings